Status:
COMPLETED
VF Mapping in Brugada and Early Repolarization Syndromes
Lead Sponsor:
Pacific Rim Electrophysiology Research Institute
Collaborating Sponsors:
University of Bordeaux
Conditions:
Brugada Syndrome
Early Repolarization Syndrome
Eligibility:
All Genders
16-70 years
Brief Summary
To determine the values and limitations of ECGI in guiding ablation and risk stratification in patients with BrS and Early Repolarization.
Detailed Description
The investigators will study symptomatic BrS and ERs syndrome (N=25) and asymptomatic patients (N=25) age between 16-70 years old to determine values and limitations of non-invasive mapping using elec...
Eligibility Criteria
Inclusion
- Patients presenting with the type1 BrS ECG or ER ECG signature pattern, with/without a sodium channel blocker. Patients with the following one of these symptoms or arrhythmias will be considered as symptomatic patients: 1) aborted cardiac arrest cases, 2) documented VF episodes, 3) agonal respiration during sleep with difficulty to arouse, 4) syncope of unknown origin, or 5) seizure suspected of arrhythmic origin.•
Exclusion
- Patients who refuse informed consent and to participate to the best ability in the study.
- Patients who have structural heart disease or concomitant medical illness.
Key Trial Info
Start Date :
February 23 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03764592
Start Date
February 23 2018
End Date
September 1 2024
Last Update
November 22 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Bumrungrad International Hospital
Bangkok, Thailand
2
Pacific Rim Electrophysiology Research Institute Data Coordinating Center
Bangkok, Thailand